https://www.washingtonpost.com/technology/2023/03/13/meta-layoffs/
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation Of Phase 2 Clinical Trial Of MYMD-1 For Extending Healthy Lifespan
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate